Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions : Comparative regulation framework of off label prescriptions in pediatrics: a review.

Background Off-label uses of medicines are common in pediatrics. The literature reports that at least one-third of children in hospital and up to 90% of newborns in neonatal intensive care units receive off-label prescriptions. Moreover, the lack of data on safety and efficacy in the pediatric population may sometimes increase the risk of adverse drug reactions.

An empirical study of healthcare providers and patients' perceptions of electronic health records.

This paper is the result of a legal and policy analysis of a statistical poll focused on the area of Livorno conducted by the LIDER-Lab of the Scuola Superiore Sant'Anna (Pisa, Italy). Information were gathered by submitting questionnaires to both healthcare providers and their patients. The scope was to evaluate the interest engendered by the application of technology on health data processing along with the needs, expectations and concerns of patients and healthcare providers.